ExPharma Limited is an company focussed on R&D and investment. We are a small but agile and highly focused team of senior individuals, with established networks and track records of entrepreneurial and investment success. We thrive on challenge and continually seek inventive solutions for both our own and clients projects. Our expertise and experience within R&D, CMC, regulatory affairs and business transactions ensures success and makes us the ideal partner to bring your concept to market. Spanning a range of sectors within health and wellness, our activities cover food supplements, foods for special medical purposes, medical devices and diagnostics and our networks extend to pharmaceutical and nutrition companies, universities and investors.
Looking for a particular ExPharma Limited employee's phone or email?
The ExPharma Limited annual revenue was $3 million in 2026.
Paolo Rampazzo is the Director of ExPharma Limited.
1 people are employed at ExPharma Limited.
The NAICS codes for ExPharma Limited are [325, 3254, 32, 32541].
The SIC codes for ExPharma Limited are [283, 28].